After dysplasia resection in patients with inflammatory bowel disease, risk for colorectal cancer was low, according to results published in Gastrointestinal Endoscopy.

“This is a novel finding of this study and seems to support the hypothesis that tumor progression in inflammatory bowel segment does not always follow the [low-grade dysplasia (LGD)] to [high-grade dysplasia (HGD)] to cancer pathway,” Babu P. Mohan, MD, from the department of gastroenterology and hepatology at the University of Utah Health, and colleague wrote. “The failure to achieve statistical significance

Full Article: